Determinants of Adherence to Option B+ Antiretroviral Therapy among HIV Positive Pregnant Women Attending Antenatal Clinics at Tertiary Health Institutions in Anambra State

Authors

  • Silas Esther A. 
  • Clementina U. Nwankwo

DOI:

https://doi.org/10.47672/ejhs.1416
Abstract views: 104
PDF downloads: 85

Keywords:

Adherence, women, HIV, positive, pregnant.

Abstract

Purpose: The study ascertained determinants of adherence to option B+ antiretroviral therapy (ART) among HIV positive pregnant women attending antenatal clinics at tertiary health institutions in Anambra state.

Methodology: A cross-sectional descriptive design was adopted in conducting the study among HIV positive pregnant women attending antenatal clinics at tertiary health institutions in Anambra state. A sample size of one hundred and forty six (146) HIV positive pregnant women was selected by purposive and convenience sampling techniques. Adult AIDS Clinical Trial Group (AACTG) standardized questionnaire was used in data collection which were analyzed with IBM SPSS software database (version 25). Chi square was used for test of hypotheses at p < 0.05 level of significance.

Findings: Results revealed that the women with parity less than 4 (105(89%) were more adherent to ART; the women with primary education as highest level of education (13(92.9%) were more adherent to ART; the women within the age range 15-25 years (32(97%) were adherent; the women working in the informal sector (31 (96.9%) were more adherent to ART. The study also showed that there is no significant relationship between the women’s level of education, parity, age and adherence to ART but there is significant relationship between the women’s occupation and adherence to ART. From the study, it was ascertained that the HIV positive pregnant woman’s parity, level of education and age are not determinants of adherence to Option B+ ART but occupation of the women is.

Recommendations: Health care providers or mentor mothers in the health care facilities should give more attention to the HIV positive pregnant women working in the informal sector and unemployed than the women working in the formal sector in regards to their adherence to ART.

Downloads

Download data is not yet available.

Author Biographies

Silas Esther A. 

Department of Nursing Science, Faculty of Health Sciences & Technology, Nnamdi  Azikiwe University, Nnewi Campus, Anambra State, Nigeria.

Clementina U. Nwankwo

Department of Nursing Science, Faculty of Health Sciences & Technology, Nnamdi  Azikiwe University, Nnewi Campus, Anambra State, Nigeria.

References

Atanga, P.N. (2016).Retention-in-Care, Adherence and Treatment outcomes in a cohort of HIVpositive pregnant and breastfeeding women enrolled in a pilot project implementing “Option B+” in Cameroon. Retrieved from https://edoc.ub.uni-muenchen.de/20643/1/Atanga_Paschal_Nji.pdf on July 15, 2021.

Calder, C.L, O’Hara, H., Tabatabai, M., Maxwell, C.J, Marryshow. S., Ahonkhai, A.A., Audet, C.M., Wester, W.C. and Muktar, H.A. (2020). Adherence to Combination Antiretroviral Therapy among Pregnant Women Enrolled in A HIV Prevention Program in Rural North-Central Nigeria. International Journal of Maternal and Child Health AIDS, 9(1), 81-92.

Darby, A. and Jones, S. (2021): World Health Organization Guidelines (Option A,B, and B+) for Antiretroviral Drugs to Treat Pregnant Women and Prevent HIV Infection in Infants’. Embryo Project Encyclopedia. ISSN: 1940-5030. Retrieved from http://embryo.asu.edu/handle/10776013231 on July 22, 2021.

Desta, A.A, Kidane K.M, Woldegebriel, A.G, Ajemu K.F, Berhe, A.A, Zgita D.N, Teweldemedhn, L.W, Woldegebriel, L.L, Bezabih, N.M and Woldearegay, T.W. (2020). Level of adherence and associated factors among HIV infected patients on antiretroviral therapy in Northern Ethiopia: Retrospective Analysis. Journal of Patient Preference and Adherence, 14: 1585-1593.

Federal Ministry of Health, FMoH [Nigeria] (2014) National HIV Sero-prevalence Sentinel Survey among Pregnant Women Attending Antenatal Clinics in Nigeria, 201 Fact Sheet. Department of Public Health National AIDS/ STI Control Programme, Abuja, Nigeria. Retrieved from http://www.hrpub.org/download/20190430/IID216713024.pdf in July, 2021.

Girma, M. (2016). Effectiveness of prevention of mother-to child transmission (PMTCT)

procedures in pregnant HIV infected women and their exposed infants at seven health centers in Addis Ababa, Ethiopia (Unpublished PhD Dissertation). Medical Faculty of

Ludwig-Maximilians-Universität, Munich.

National Agency for the Control of AIDS, NACA (2016) Global AIDS Response – Country Progress Report (Nigeria GARPR 2015). NACA, Abuja, Nigeria. Retrieved from http://www.hrpub.org/download/20190430/IID216713024.pdf on July, 2021.

Obonyo, F.F.A (2016). Non Adherence to Pmtct Treatment and Loss to Follow Up of

Hiv Positive Mothers and Babies In Mombasa County, Kenya (Unpublished masters’ thesis). School Of Public Health, Kenyatta University.

Oginni, M.O., Aremu, O.O., Olowokere, A.E., Ayamolowo, S.J. and Komolafe, A.O. (2018). Adherence to HIV Care among HIV Positive Pregnant Women in Nigeria. African Journal of Midwifery and Women’s Health, 12(1), 28-34.

Omonaiye, O., Kusljic, S., Nicholson, P., Mohebbi, M. and Manias, E. (2019). Post Option B+ Implementation Programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV. International Journal of Infectious Diseases, 81: 225-230.

Pietrangelo, A. (2021). What You Should Know about HIV in Children. Retrieved from www.healthline.com/health/hiv-in-children on 16th August, 2021.

United Nations Programme on HIV and AIDS, UNAIDS (2018) Ending the AIDS Epidemic, Fact Sheet [online]. Retrieved from http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Fact Sheet _en.pdf on July, 2021.

UNAIDS (2022). Full report-In Danger: UNAIDS Global AIDS Update 2022. Retrieved from http://www.unaids.org/en/resources/documents/2022/in-danger-global-aids-update in 2022.

Wedminere, N.Z., Lucresse C.F., Calypse, N., Sekou, S., Isidore, T.T., Herve H., Fidele B., Maxime D. and Fati, K. (2022). Adherence to HIV antiretroviral therapy among pregnant and breastfeeding women, non-pregnant women and men in Burkina Faso: Nationwide Analysis 2019-2020. Journal of Patient Preference and Adherence, 16: 1037-1047.

World Health Organization (2016). Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. World Health Organization; 2016. Retrieved from https://www.who.int/publications/i/item/978924159684 on July, 2021

Wondimu, F., Yetwale, F., Admassu E., Binu, W., Abdissa Bulto, G., Lake, G., Girmaye, E., Temesgen, K. and Marama, G. (2020). Adherence to Option B+ Care for the Prevention of Mother-to-Child Transmission among Pregnant Women in Ethiopia. HIV/AIDS - Research and Palliative Care, 12, 769–778.

Zacharius, K.M., Basinda, N., Marwa, K., Mtui, E.H., Kalolo, A., Kapesa, A. (2019). Low adherence to Option B+ antiretroviral therapy among pregnant women and lactating mothers in eastern Tanzania. PLoS ONE, 14(2): e0212587.

Downloads

Published

2023-04-10

How to Cite

Silas , E. A., & Nwankwo, C. U. (2023). Determinants of Adherence to Option B+ Antiretroviral Therapy among HIV Positive Pregnant Women Attending Antenatal Clinics at Tertiary Health Institutions in Anambra State. European Journal of Health Sciences, 8(1), 28 - 41. https://doi.org/10.47672/ejhs.1416